Pharmacy Times: Given the increasing role of digital health tools, what barriers remain before accelerometry-based endpoints can be validated and adopted for regulatory or clinical decision-making?
Biykem Bozkurt, MD, PhD, FACC: Several barriers….

Pharmacy Times: Given the increasing role of digital health tools, what barriers remain before accelerometry-based endpoints can be validated and adopted for regulatory or clinical decision-making?
Biykem Bozkurt, MD, PhD, FACC: Several barriers….